Comparative integromics on Ephrin family

Oncology Reports

Volumn 15, Issue 5, 2006, Pages 1391-1395

  Katoh, Yuriko ^a   Katoh, Masaru ^b  

^a M&M Medical BioInformatics   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Bioinformatics; Comparative genomics; Comparative proteomics; EFN; EPH; Integrome network; WNT

Indexed keywords

EPHRIN RECEPTOR; LIGAND; T CELL FACTOR PROTEIN; WNT PROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; CATTLE; COMPARATIVE STUDY; GENETICS; GENOME; GENOMICS; HUMAN; INTEGRON; METABOLISM; MOLECULAR GENETICS; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PAN TROGLODYTES; PROMOTER REGION; PROTEOMICS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BINDING SITES; CATTLE; CONSERVED SEQUENCE; GENOME, HUMAN; GENOMICS; HUMANS; INTEGRONS; LIGANDS; MOLECULAR SEQUENCE DATA; MULTIGENE FAMILY; PAN TROGLODYTES; PROMOTER REGIONS (GENETICS); PROTEOMICS; RECEPTORS, EPH FAMILY; SEQUENCE HOMOLOGY, AMINO ACID; SEQUENCE HOMOLOGY, NUCLEIC ACID; TCF TRANSCRIPTION FACTORS; WNT PROTEINS;

EID: 33744976593     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.5.1391     Document Type: Article

References (50)

1. Davis S, Gale NW, Aldrich TH, et al: Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266: 816-819, 1994. (Pubitemid 24359293)
2. Beckmann MP, Cerretti DP, Baum P, et al: Molecular characterization of a family of ligands for eph-related tyrosine kinase receptors. EMBO J 13: 3757-3762, 1994. (Pubitemid 24275021)
3. Fletcher FA, Huebner K, Shaffer LG, et al: Assignment of the gene (EPLG2) encoding a high-affinity binding protein for the receptor tyrosine kinase elk to a 200-kilobasepair region in human chromosome Xq12. Genomics 25: 334-335, 1995.
4. Bennett BD, Zeigler FC, Gu Q, et al: Molecular cloning of a ligand for the EPH-related receptor protein-tyrosine kinase Htk. Proc Natl Acad Sci USA 92: 1866-1870, 1995.
5. Pandey A, Lindberg RA and Dixit VM: Cell signalling. Receptor orphans find a family. Curr Biol 5: 986-989, 1995.
6. Cerretti DP, Lyman SD, Kozlosky CJ, et al: The genes encoding the eph-related receptor tyrosine kinase ligands LERK-1 (EPLG1, Epl1), LERK-3 (EPLG3, Epl3), and LERK-4 (EPLG4, Epl4) are clustered on human chromosome 1 and mouse chromosome 3. Genomics 33: 277-282, 1996.
7. Cerretti DP, Copeland NG, Gilbert DJ, et al: The gene encoding LERK-7 (EPLG7, Epl7), a ligand for the Eph-related receptor tyrosine kinases, maps to human chromosome 5 at band q21 and to mouse chromosome 17. Genomics 35: 376-379, 1996. (Pubitemid 26250326)
8. Gale NW, Flenniken A, Compton DC, et al: Elk-L3, a novel transmembrane ligand for the Eph family of receptor tyrosine kinases, expressed in embryonic floor plate, roof plate and hind-brain segments. Oncogene 13: 1343-1352, 1996. (Pubitemid 26343588)
9. Gale NW, Holland SJ, Valenzuela DM, et al: Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 17: 9-19, 1996. (Pubitemid 26251587)
10. Aasheim HC, Pedeutour F, Grosgeorge J and Logtenberg T: Cloning, chromosal mapping, and tissue expression of the gene encoding the human Eph-family kinase ligand ephrin-A2. Biochem Biophys Res Commun 252: 378-382, 1998. (Pubitemid 28542895)
11. Flanagan JG and Vanderhaeghen P: The ephrins and Eph receptors in neural development. Annu Rev Neurosci 21: 309-345, 1998. (Pubitemid 28150666)
12. Holder N and Klein R: Eph receptors and ephrins: effectors of morphogenesis. Development 126: 2033-2044, 1999. (Pubitemid 29271689)
13. Frisen J, Holmberg J and Barbacid M: Ephrins and their multi-talented directors of embryonic development. EMBO J 18: 5159-5165, 1999. (Pubitemid 29465566)
14. Wilkinson DG: Multiple roles of Eph receptors and ephrinin neural development. Nat Rev Neurosci 2: 155-164, 2001.
15. Mancia F and Shapiro L: ADAM and Eph: how Ephrin-signaling cells become detached. Cell 123: 185-187, 2005. (Pubitemid 41457207)
16. Katoh M: WNT and FGF gene clusters. Int J Oncol 21: 1269-1273, 2002.
17. Katoh M: Regulation of WNT signaling molecules by retinoic acid during neuronal differentiation in NT2 cells: threshold model of WNT action. Int J Mol Med 10: 683-687, 2002.
18. Heller RS, Klein T, Ling Z, Heimberg H, Katoh M, Madsen OD and Serup P: Expression of WNT, Frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expr 11: 141-147, 2003. (Pubitemid 37516647)
19. Katoh M: WNT2 and human gastrointestinal cancer. Int J Mol Med 12: 811-816, 2003.
20. Katoh M and Katoh M: Identification and characterization of human BCL9L gene and mouse Bcl9l gene in silico. Int J Mol Med 12: 643-649, 2003.
21. Garciadiego-Cazares D, Rosales C, Katoh M and Chimal-Monroy J: Coordination of chondrocyte differentiation and joint formation by α5β1 integrin in the developing appendicular skeleton. Development 131: 4735-4742, 2004. (Pubitemid 39433460)
22. Katoh M and Katoh M: Comparative genomics on WNT8A and WNT8B genes. Int J Oncol 26: 1129-1133, 2005.
23. Katoh M: Molecular evolution of WNT2B orthologs. Int J Oncol 26: 1135-1139, 2005.
24. Katoh M: Comparative genomics on WNT3-WNT9B gene cluster. Int J Mol Med 15: 743-747, 2005.
25. Swain RK, Katoh M, Medina A and Steinbeisser H: Xenopus frizzled-4S, a splicing variant of Xfz4, is a context-dependent activator and inhibitor of Wnt/β-catenin signaling. Cell Commun Signal 3: 12, 2005.
26. Katoh M: Epithelial-mesenchymal transition in gastric cancer. Int J Oncol 27: 1677-1683, 2005.
27. Katoh M: WNT2B: comparative integromics and clinical application. Int J Mol Med 16: 1103-1108, 2005.
28. Katoh Y and Katoh M: Comparative genomics on DKK1 orthologs. Int J Oncol 27: 275-279, 2005.
29. Katoh Y and Katoh M: Comparative genomics on DKK2 and DKK4 orthologs. Int J Mol Med 16: 477-481, 2005.
30. Katoh M and Katoh M: Comparative genomics on FGF20 orthologs. Oncol Rep 14: 287-290, 2005.
31. Katoh M and Katoh M: Comparative genomics on FGF8, FGF17, and FGF18 orthologs. Int J Mol Med 16: 493-496, 2005.
32. Katoh Y and Katoh M: Comparative genomics on FGF16 orthologs. Int J Mol Med 16: 959-963, 2005.
33. Battle E, Henderson JT, Beghtel H, et al: β-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/EphrinB. Cell 111: 251-263, 2002. (Pubitemid 35292445)
34. Batlle E, Bacani J, Begthel H, et al: EphB receptor activity suppresses colorectal cancer progression. Nature 435: 1126-1130, 2005. (Pubitemid 40910522)
35. Katoh M: Paradigm shift in gene-finding method: from bench-top approach to desk-top approach. Int J Mol Med 10: 677-682, 2002.
36. Katoh M and Katoh M: Evolutionary conservation of CCND1-ORAOV1-FGF19-FGF4 locus from zebrafish to human. Int J Mol Med 12: 45-50, 2003.
37. Katoh M and Katoh M: CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int J Mol Med 11: 683-689, 2003.
38. Katoh M and Katoh M: Identification and characterization of human MPP7 gene and mouse Mpp7 gene in silico. Int J Mol Med 13: 333-338, 2004.
39. Katoh M and Katoh M: Identification and characterization of Crumbs homolog 2 gene at human chromosome 9q33.3. Int J Oncol 24: 743-749, 2004.
40. Katoh M and Katoh M: Identification and characterization of human HES2, HES3, and HES5 genes in silico. Int J Oncol 25: 529-534, 2004.
41. Katoh M and Katoh M: Identification and characterization of human HESL, rat Hesl and rainbow trout hesl genes in silico. Int J Mol Med 14: 747-751, 2004.
42. Katoh M and Katoh M: Comparative genomics on WNT5A and WNT5B genes. Int J Mol Med 15: 749-753, 2005.
43. Katoh Y and Katoh M: Comparative genomics on WNT11 gene. Int J Mol Med 15: 879-883, 2005.
44. Katoh Y and Katoh M: Comparative genomics on VANGL1 and VANGL2 genes. Int J Oncol 26: 1435-1440, 2005.
45. Katoh Y and Katoh M: Comparative genomics on SFRP1 orthologs. Int J Oncol 27: 861-865, 2005.
46. Katoh Y and Katoh M: WNT antagonist, SFRP1, is Hedgehog signaling target. Int J Mol Med 17: 171-175, 2006.
47. Katoh Y and Katoh M: Comparative genomics on HHIP family orthologs. Int J Mol Med 17: 391-395, 2006.
48. Kullander K, Croll SD, Zimmer M, et al: Ephrin-B3 is the midline barrier that prevents corticospinal tract axons from recrossing, allowing for unilateral motor control. Genes Dev 15: 877-888, 2001. (Pubitemid 32295068)
49. Kullander K, Butt SJ, Lebret JM, et al: Role of EphA4 and EphrinB3 in local neuronal circuits that control walking. Science 299: 1889-1892, 2003. (Pubitemid 36358203)
50. Benson MD, Romero MI, Lush ME, et al: Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc Natl Acad Sci USA 102: 10694-10699, 2005. (Pubitemid 41061616)